Monashee Investment Management LLC X4 Pharmaceuticals, Inc Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.03 - $2.02 $149,884 - $293,948	-145,519 Reduced 25.41%	427,265 $465,000
Q2 2023 Aug 10, 2023	BUY	$0.82 - $2.49 $469,682 - $1.43 Million	572,784 New	572,784 $1.11 Million
Q4 2021 Feb 07, 2022	SELL	$1.9 - $5.6 $1.07 Million - $3.14 Million	-561,421 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$4.53 - $6.45 $60,208 - $85,726	-13,291 Reduced 2.31%	561,421 $2.97 Million
Q1 2021 May 14, 2021	BUY	$6.63 - $10.28 $3.81 Million - $5.91 Million	574,712 New	574,712 $4.95 Million

105

100M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.